Ponatinib

ATC L01EA05 · 9 markets · 28 records

Ponatinib 9 markets · 28 records Forms

AU 7 records · 7 strengths

  • 15 mgtabletIclusig also in GB·US·ES +3
  • 45 mgtabletIclusig also in GB·US·ES +1
  • 48.1 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle unknown
  • 32.05 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle unknown
  • 16 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle unknown
  • 10.68 mgtabletICLUSIG ponatinib (as hydrochloride) 15 mg film-coated tablet bottle unknown

Records without a stated strength · 1 Iclusig

GB 6 records · 3 strengths

US 4 records · 4 strengths

ES 3 records · 3 strengths

SG 2 records · 2 strengths

HK 2 records · 1 strengths

    Records without a stated strength · 1 Iclusig

    CA 1 records · 1 strengths

    CN 1 records · 1 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Iclusig

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.